Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Hengtai Jiukang Biotechnology is a specialized biotechnology enterprise headquartered in Beijing, China, focusing on the fields of cell therapy and biological resource preservation. The company provides a comprehensive suite of services including immune cell and stem cell storage, technology development for cell-based treatments, and the production of high-quality biological reagents. Hengtai Jiukang collaborates with clinical institutions to advance regenerative medicine and oncology treatments through its standardized cell processing and quality control systems. Their business model integrates research and development with technical consulting and laboratory services to support the broader life sciences industry. By bridging the gap between laboratory research and clinical application, the company supports healthcare providers in the implementation of personalized medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hengtai Jiukang.